Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension-Reference-Cited by-同舟云学术

Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension

Published:2022-11-10 Issue:2 Volume:128 Page:354-362
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

van Doorn Leni,Visser Wesley J.,van Dorst Daan C. H.,Mirabito Colafella Katrina M.,Koolen Stijn L. W.,de Mik Anneke van Egmond-,Garrelds Ingrid M.,Bovée Dominique M.,de Hoop Esther Oomen-^ORCID,Bins Sander^ORCID,Eskens Ferry A. L. M.,Hoorn Ewout J.,Jan Danser A. H.,Mathijssen Ron H. J.,Versmissen Jorie^ORCID

Funder

Dutch foundation De Merel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-022-02036-6.pdf

Reference42 articles.

1. Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov. 2016;15:385–403.

2. Moslehi JJ. Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med. 2016;375:1457–67.

3. van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, et al. Hypertension and prohypertensive antineoplastic therapies in cancer patients. Circ Res. 2021;128:1040–61.